Imatinib vs Osimertinib
Imatinib vs Osimertinib: Overview
This comparison examines the pharmacological differences between Imatinib and Osimertinib.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Imatinib — 18 hours; Osimertinib — 48 hours.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O; Osimertinib — C28H33N7O2.
Molecular Weight: Imatinib — 493.6030 g/mol; Osimertinib — 499.6050 g/mol.
Type: Imatinib — Small molecule; Osimertinib — Small molecule.